Natasha Rekhtman

25PUBLICATIONS
231CO-AUTHORS
Molecular targetsHaematological tumoursCentral nervous systemPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 24, 2026
Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

|Feb 23, 2026
Evolution of oncogene amplification across 86,000 cancer cell genomes.

Jake June-Koo Lee, Sohrab Salehi, Matthew A Myers

|Nov 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Rohit Thummalapalli, Salomon Tendler, Joanne F Chou

|Sep 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas.

Jessica S Ross, Rohit Thummalapalli, Kristine Lacuna

|Sep 05, 2025
Seizure-Related Homolog Protein 6 (SEZ6): Biology and Therapeutic Target in Neuroendocrine Carcinomas.

Emelie Gezelius, Natasha Rekhtman, Marina K Baine

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

Pageof 5

Frequent Collaborators

15 joint publications

Charles M Rudin

7 joint publications

Michael Offin

6 joint publications

Alexander Drilon

5 joint publications

Marina K Baine